Rafael Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RFL research report →
Price Chart
About the company
Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate.
- CEO
- Howard S. Jonas
- IPO
- 2018
- Employees
- 22
- HQ
- Newark, NJ, US
Get TickerSpark's AI analysis on RFL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $76.09M
- P/E
- -2.18
- PEG
- -0.07
- P/S
- 77.64
- P/B
- 1.01
- EV/EBITDA
- -1.49
- Div Yield
- 0.00%
- Gross Margin
- 84.39%
- Op Margin
- -3717.24%
- Net Margin
- -3321.73%
- ROE
- -38.97%
- ROIC
- -44.50%
Latest fiscal year · YoY change
- Revenue
- $917.00K+44.0%
- Gross Profit
- $495.00K+2.5%
- Op Income
- $-26,109,000
- Net Income
- $-30,520,000+11.3%
- EPS
- $-1.04+28.3%
- OCF Growth
- -142.6%
- FCF Growth
- -137.2%
- 52W High
- $3.96
- 52W Low
- $1.12
- 50D MA
- $2.07
- 200D MA
- $1.67
- Beta
- 0.35
- RSI (14)
- 32
- Avg Volume
- 166.57K
No earnings-call transcripts are available for RFL yet.
- Free Float
- 62.0%
- Shares Outstanding
- 51.21M
- Float Shares
- 31.77M
of shares held by institutions
42 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 1.49M | ▲ 98.55K |
| Vanguard Capital Management LLC | 1.37M | ▲ 106.09K |
| Geode Capital Management, LLC | 429.88K | ▼ 12.53K |
| Blackrock, Inc. | 390.07K | ▲ 24.45K |
| Dimensional Fund Advisors LP | 278.91K | 0 |
| Vanguard Fiduciary Trust Co | 206.52K | ▲ 1.57K |
| Founders Fund V Management, LLC | 169.45K | 0 |
| Ieq Capital, LLC | 164.96K | ▼ 25.00K |
| State Street Corp | 157.27K | ▲ 95.10K |
| Kahn Brothers Group Inc | 150.49K | ▲ 91.94K |
| Jane Street Group, LLC | 112.72K | ▲ 67.67K |
| Wells Fargo & Company/Mn | 103.59K | ▲ 239 |
Held by 37 ETFs
Biggest fund positions in RFL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 21, 26 | Polinsky David | other | 2,027 |
| Jul 29, 26 | JONAS HOWARD S | other | 54,945 |
| Jun 21, 26 | Polinsky David | other | 2,386 |
| Jun 13, 26 | JONAS HOWARD S | other | 142,857 |
| Jun 13, 26 | JONAS HOWARD S | other | 8,786 |
| Mar 21, 26 | Polinsky David | other | 2,318 |
| Mar 13, 26 | JONAS HOWARD S | other | 9,826 |
| Jan 28, 26 | Sieger Markus | other | 29,528 |
| Jan 28, 26 | WEISS MICHAEL J | other | 39,370 |
| Jan 28, 26 | STEIN MARK N | other | 39,370 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RFL coverage
Recent articles, reports, and earnings notes.
No research on RFL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RFL report →Rafael's Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing
marketbeat.com · Oct 4
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
gurufocus.com · Oct 3
Rafael Holdings, Inc. (RFL) Discusses Topline Results of Phase III TransportNPC Study of Trappsol Cyclo in Niemann-Pick Disease Type C Transcript
seekingalpha.com · Sep 30
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
globenewswire.com · Sep 30
Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development
newsfilecorp.com · Aug 5
Head to Head Comparison: Oncology Pharma (OTCMKTS:ONPH) & Rafael (NYSE:RFL)
defenseworld.net · Jul 28
Manhattan Uranium Identifies High-Grade Uranium Intercepts from 5,668-Hole Database Compilation at I-70, San Rafael District, Utah
newsfilecorp.com · Jul 23
Sekur Private Data Appoints Special Operations Communications Chief Master Sergeant (Ret.) Rafael Beltran to Its OpsTech Special Advisory Board
accessnewswire.com · Jul 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.